Investor alert: pomerantz law firm investigates claims on behalf of investors of praxis precision medicines, inc. - prax

New york, aug. 13, 2025 (globe newswire) -- pomerantz llp is investigating claims on behalf of investors of praxis precision medicines, inc. (“praxis” or the “company”) (nasdaq: prax). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PRAX Ratings Summary

PRAX Quant Ranking